C3 Glomerulopathy clinical trials at UCLA
1 in progress, 0 open to eligible people
Showing trials for
Nonrandomized, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan in Participants With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis
Sorry, in progress, not accepting new patients
This study is designed as a long-term extension to Study APL2-C3G-310, and is being conducted to establish the long-term safety and efficacy of pegcetacoplan in patients with C3 glomerulopathy (C3G) or immune-complex membranoproliferative glomerulonephritis (IC-MPGN).
Los Angeles, California and other locations
Our lead scientists for C3 Glomerulopathy research studies include Suphamai Bunnapradist, MD, MS.
Last updated: